drugset / Trial / NCT06752174
A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
The goal of this clinical trial is to evaluate the immunogenicity and safety of a Sabin Inactivated Poliomyelitis Vaccine (sIPV) and a commercially available Live Attenuated Poliomyelitis Vaccine (bOPV) according to the "2+1 sequential" immunization program (sIPV-sIPV-bOPV) in 2-month-old healthy infants.
Timeline
- Start
- 2023-03-08
- Primary completion
- 2024-04-12
- Completion
- 2024-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sabin Inactivated Poliomyelitis Vaccine | Vaccine | — | — |
| Comparator | wIPV | Vaccine | — | — |
| Background | Live Attenuated Poliomyelitis Vaccine | Vaccine | — | — |
| Comparator | Live Attenuated Poliomyelitis Vaccine | Vaccine | — | — |